Global Transplant Diagnostics Market is estimated to value over USD 5.1 billion by 2026 end and register a CAGR of over 6.4% during the forecast period 2019 to 2026.
The factors steering the global transplant diagnostics market growth are rising adoption of transplant diagnostic techniques in respective research studies and increasing focus on early and effective profiling of patients during the process of organ transplantation. The transplant diagnostics market is bifurcated into software and services, instruments, reagents and consumables. The reagents and consumables segment held the largest global transplant diagnostics market share in 2018.
Molecular Assays Technology Segment is Predicted to Record the Highest CAGR Over the Forecast Period
The market is bifurcated based on the type of technology as non-molecular assays and molecular assays. The segment that is anticipated to record a high CAGR value over the forecast period is the molecular assay technology segment. Factors such as raising private and public investments to bolster the development of products, its variety of applications related to profiling the patients and rising clinical evidence in order to establish the effectiveness of molecular assay methods are steering the segment growth.
The solid-organ transplantation segment is projected to hold the largest market share during the forecast period. The reassuring regulations of the government to increase the donation of organs across key healthcare markets, an increasing number of persistent disorders diseases that results into transplantation and current advancements in technology are the crucial factors expanding the global transplant diagnostics market size.
Regionally, the market is fragmented into Europe, Asia Pacific, North America and the rest of the world. The North American region holds the largest market share and this can be credited to the consistent innovation of transplant diagnostic products along with current technological advancements in proteomics and genomics, recently discovered genetic biomarkers and their role in testing immunoassays and growing incidences of communicable and persistent diseases.
Key players included in the global transplant diagnostics industry are Becton, Dickinson and Co., Biofortuna, Biomerieux SA, Bio-Rad Laboratories, Caredx, F.Hoffman-La Roche Ltd., Gendx, Hologic, illumine, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=250&page=requestsample
Global Transplant Diagnostics Market Segmentation:
By Product and Services
• Reagents
• Instruments
• Software and Services
By Technology
• Molecular Assays
1. PCR-Based Molecular Assays
1. Real-Time PCR
2. Sequence-Specifier Primer-PCR
3. Sequence-Specific Oligonucleotide-PCR
4. Others PCR-Based Molecular Assays
2. Sequence-Based Molecular Assays
1. Sanger Sequencing
2. Next-Generation Sequencing
3. Others Sequencing Molecular Assays
• Non-Molecular Assays
By Transplant Type
• Solid Organ Transplant
1.
1. Kidney Transplant
2. Liver Transplant
3. Heart Transplant
4. Lung Transplant
5. Pancreas Transplant
6. Other Organ Transplantations
• Stem Cell Transplant
• Soft Tissue Transplant
By Application
• Diagnostic Applications
1.
1. Pre-Transplantation Diagnostics
1. Infectious Disease Testing
2. Histocompatibility Testing
3. Blood Profiling
2. Post-Transplantation Diagnostics
• Research Applications
By End User
• Independent Reference Laboratories
• Hospitals & Transplant Centres
• Research Laboratories & Academic Institutes
By Region
• North America
• Europe
• Asia Pacific
• Rest of the World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=250&page=askfordiscount

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global transplant diagnostics market by product and services, by technology, by transplant type, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Major Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Procedure Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary

4 Exclusive Insights
4.1 Transplant Diagnostics Market Overview
4.2 Transplant Diagnostics Market, By Technology
4.3 Regional Analysis: Transplant Diagnostics Market, By Application
4.4 Asia Pacific: Transplant Diagnostics Market, By End User, 2018
4.5 Regional Analysis: Transplant Diagnostics Market, By Product & Service
4.6 Regional Analysis: Transplant Diagnostics Market, By Transplant Type
4.7 Transplant Diagnostics Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Increasing Number of Transplant Procedures
5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics
5.2.1.3 Increasing Public-Private Funding for Target Research Activities
5.2.1.4 Growing Burden of Infectious Diseases
5.2.2 Key Market Restraints
5.2.2.1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays
5.2.2.2 Limited Reimbursements for Target Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Rising Adoption of Cross Matching and Chimerism Testing During Pre- & Post-Transplantation
5.2.3.2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Product and Services
6.1 Introduction
6.2 Reagents and Consumables
6.3 Instruments
6.4 Software and Services

7 Transplant Diagnostics Market, By Technology
7.1 Introduction
7.2 Molecular Assays
7.2.1 PCR-Based Molecular Assays
7.2.1.1 Real-Time PCR
7.2.1.2 Sequence-Specific Primer-PCR
7.2.1.3 Sequence-Specific Oligonucleotide-PCR
7.2.1.4 Other PCR-Based Molecular Assays
7.2.2 Sequencing-Based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.2 Next-Generation Sequencing
7.2.2.3 Other Sequencing Molecular Assays
7.3 Non-Molecular Assays

8 Transplant Diagnostics Market, By Transplant Type
8.1 Introduction
8.2 Solid Organ Transplant
8.2.1 Kidney Transplant
8.2.2 Liver Transplant
8.2.3 Heart Transplant
8.2.4 Lung Transplant
8.2.5 Pancreas Transplant
8.2.6 Other Organ Transplantations
8.3 Stem Cell Transplant
8.4 Soft Tissue Transplant

9 Transplant Diagnostics Market, By Application
9.1 Introduction
9.2 Diagnostic Applications
9.2.1 Pre-Transplantation Diagnostics
9.2.1.1 Infectious Disease Testing
9.2.1.2 Histocompatibility Testing
9.2.1.3 Blood Profiling
9.2.2 Post-Transplantation Diagnostics
9.3 Research Applications

10 Transplant Diagnostics Market, By End User
10.1 Introduction
10.2 Independent Reference Laboratories
10.3 Hospitals & Transplant Centers
10.4 Research Laboratories & Academic Institutes

11 Transplant Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Key Product Launches and Enhancements (2014 to 2018)
12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018)
12.3.3 Major Acquisitions (2014 to 2018)
12.3.4 Key Expansions (2014 to 2018)

13 Company Profiles
13.1 Introduction
13.2 Becton, Dickinson and Company
13.3 Biofortuna
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories
13.6 Caredx
13.7 F. Hoffman-La Roche Limited
13.8 Gendx
13.9 Hologic
13.10 Illumina
13.11 Immucor
13.12 Luminex
13.13 Merck KGaA
13.14 Omixon
13.15 Qiagen
13.16 Thermo Fisher Scientific


Chapter 14 Research Finding and Conclusion

Chapter 15 Research Methodology

Chapter 16 Research Data Source

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com